These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer. Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339 [TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. Hatami A; Albay R; Monjazeb S; Milton S; Glabe C J Biol Chem; 2014 Nov; 289(46):32131-32143. PubMed ID: 25281743 [TBL] [Abstract][Full Text] [Related]
51. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice. Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663 [TBL] [Abstract][Full Text] [Related]
52. Administration of amyloid-β42 oligomer-specific monoclonal antibody improved memory performance in SAMP8 mice. Zhang Y; He JS; Wang X; Wang J; Bao FX; Pang SY; Yin F; Hu HG; Peng XL; Sun WM; Zheng YP; Hou LL; Hong T J Alzheimers Dis; 2011; 23(3):551-61. PubMed ID: 21297277 [TBL] [Abstract][Full Text] [Related]
55. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease. Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995 [TBL] [Abstract][Full Text] [Related]
56. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models. Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699 [TBL] [Abstract][Full Text] [Related]
57. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075 [TBL] [Abstract][Full Text] [Related]
58. Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation. Boado RJ; Zhang Y; Zhang Y; Xia CF; Pardridge WM Bioconjug Chem; 2007; 18(2):447-55. PubMed ID: 17315944 [TBL] [Abstract][Full Text] [Related]
59. Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model. Morales-Corraliza J; Schmidt SD; Mazzella MJ; Berger JD; Wilson DA; Wesson DW; Jucker M; Levy E; Nixon RA; Mathews PM Neurobiol Aging; 2013 Jan; 34(1):137-45. PubMed ID: 22608241 [TBL] [Abstract][Full Text] [Related]
60. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains. Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]